摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

Kobalt(II)-succinat | 3267-76-3

中文名称
——
中文别名
——
英文名称
Kobalt(II)-succinat
英文别名
Cobalt succinate;butanedioate;cobalt(2+)
Kobalt(II)-succinat化学式
CAS
3267-76-3
化学式
C4H4O4*Co
mdl
——
分子量
175.067
InChiKey
XENHXPKUQLUHCZ-UHFFFAOYSA-L
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    -2.74
  • 重原子数:
    9
  • 可旋转键数:
    1
  • 环数:
    0.0
  • sp3杂化的碳原子比例:
    0.5
  • 拓扑面积:
    80.3
  • 氢给体数:
    0
  • 氢受体数:
    4

ADMET

代谢
通过肺部、胃肠系统和皮肤被吸收。由于它是维生素B12(胺)的一个组成部分,因此它被分布到身体的大多数组织中。它在血液中运输,通常与白蛋白结合,肝脏和肾脏中的含量最高。主要通过尿液和粪便排出。
Cobalt is absorbed though the lungs, gastrointestinal tract, and skin. Since it is a component of the vitamin B12 (cyanocobalamin), it is distributed to most tissues of the body. It is transported in the blood, often bound to albumin, with the highest levels being found in the liver and kidney. Cobalt is excreted mainly in the urine and faeces. (L29)
来源:Toxin and Toxin Target Database (T3DB)
毒理性
  • 毒性总结
识别和使用:醋酸是一种固体。它用于维生素制剂和治疗剂。人类接触和毒性:无数据可用。动物研究:无数据可用。
IDENTIFICATION AND USE: Cobaltous succinate is a solid. It is used in vitamin preparations and therapeutic agents. HUMAN EXPOSURE AND TOXICITY: There are no data available. ANIMAL STUDIES: There are no data available.
来源:Hazardous Substances Data Bank (HSDB)
毒理性
  • 毒性总结
被认为通过氧化剂和自由基过程表现出其毒性。它产生氧自由基,并可能被氧化成离子态的,导致脂质过氧化增加、DNA损伤,并诱导某些酶,导致细胞凋亡。还被证明可以阻断无机通道,可能损害神经传递。还可以与辛酸螯合,损害丙酮酸脂肪酸的氧化。此外,可能通过与指DNA修复蛋白相互作用来抑制DNA修复,并且已被证明可以抑制血红素合成和葡萄糖代谢。可能激活特定的辅助性T淋巴细胞,并直接与免疫蛋白(如抗体IgA和IgE或Fc受体)相互作用,导致免疫致敏。(L29)
Cobalt is believed to exhibit its toxicity through a oxidant-based and free radical-based processes. It produces oxygen radicals and may be oxidized to ionic cobalt, causing increased lipid peroxidation, DNA damage, and inducing certain enzymes that lead to cell apoptosis. Cobalt has also been shown to block inorganic calcium channels, possibly impairing neurotransmission. Cobalt can also chelate lipoic acids, impairing oxidation of pyruvate or fatty acids. In addition, cobalt may inhibit DNA repair by interacting with zinc finger DNA repair proteins, and has also been shown to inhibit heme synthesis and glucose metabolism. Cobalt may activate specific helper T-lymphocyte cells and interact directly with immunologic proteins, such as antibodies (IgA and IgE) or Fc receptors, resulting in immunosensitization. (L29)
来源:Toxin and Toxin Target Database (T3DB)
毒理性
  • 致癌性证据
化合物在人类中的致癌性证据不足。有充分证据表明属粉末在实验动物中具有致癌性。有限证据显示含有属合在实验动物中具有致癌性。总体评估:化合物可能对人类具有致癌性(2B组)。
There is inadequate evidence for the carcinogenicity of cobalt and cobalt compounds in humans. There is sufficient evidence for the carcinogenicity of cobalt metal powder in experimental animals. There is limited evidence for the carcinogenicity of metal alloys containing cobalt, chromium and molybdenum in experimental animals. ... Overall Evaluation: Cobalt and cobalt compounds are possibly carcinogenic to humans (Group 2B). /Cobalt and cobalt compounds/
来源:Hazardous Substances Data Bank (HSDB)
毒理性
  • 致癌性证据
A3:已确认的动物致癌物,对人类的相关性未知。/的无机化合物/
A3: Confirmed animal carcinogen with unknown relevance to humans. /Cobalt and inorganic compounds, as Co/
来源:Hazardous Substances Data Bank (HSDB)
毒理性
  • 致癌性证据
和释放离子的化合物根据实验动物研究中充分的致癌性证据以及对致癌机制研究的支持数据,可以合理预期为人类致癌物。/化合物/
Cobalt and cobalt compounds that release cobalt ions in vivo are reasonably anticipated to be human carcinogens based on sufficient evidence of carcinogenicity from studies in experimental animals and supporting data from studies on mechanisms of carcinogenesis. /Cobalt and cobalt compounds/
来源:Hazardous Substances Data Bank (HSDB)

安全信息

  • 海关编码:
    2917190090

反应信息

  • 作为反应物:
    描述:
    三异丙醇胺Kobalt(II)-succinat 为溶剂, 反应 3.0h, 以60%的产率得到[(CoII)2(tris(2-hydroxypropyl)amine)2(succinato)]
    参考文献:
    名称:
    三(2-羟丙基)胺与生物活性羧酸的 NiII、ZnII、CuII 和 CoII 盐的合成和结构
    摘要:
    合成了新的三甲基氢金属特拉烷、三(2-羟丙基)胺配合物与 NiII、ZnII、CuII 和 CoII 盐的生物活性羧酸(苯甲酸、肉桂酸、水杨酸、琥珀酸)。三(2-羟丙基)胺与肉桂酸镍(II)络合物的结构由单晶X射线衍射确定。合成的三(2-羟丙基)胺配合物的热稳定性与三(2-羟乙基)-胺配合物的热稳定性进行了比较。
    DOI:
    10.1007/s11172-020-2855-y
  • 作为产物:
    描述:
    参考文献:
    名称:
    OCHNEVA V. A.; KONOVA N. M.; DYADCHENKO A. I.; POPOVA Z. G.; PANKOVA T. A+, SINTEZ I ISSLED. EHFFEKTIV. XIMIKATOV DLYA POLIMER. MATER. TEZ. DOKL. K 8+
    摘要:
    DOI:
点击查看最新优质反应信息

文献信息

  • Synthesis and Equilibrium Studies of Mixed‐Ligand Complexes of Co(II), Ni(II), and Cu(II) with Some Aliphatic Dicarboxylic Acids and Creatinine
    作者:Iman T. Ahmed
    DOI:10.1081/sim-120030438
    日期:2004.3
  • ——
    作者:M. A Moustafa、Z. A. Omran、W. A. A. Bayoumy、M. A. Mousa
    DOI:10.1023/a:1010174828300
    日期:——
    The kinetic description and mechanism of the solid-state reactions between metal basic carbonate (M=Co2+, Cu2+ and Zn2+) and aliphatic carboxylic acids (oxalic, tartaric, succinic and citric acids) were studied using non-isothermal analysis (TG, DTA) and capillary techniques. The reactions were found to proceed in all cases (except citric acid) by one mole of metal carbonate and two moles of metal carbonate and two moles of organic acid. The kinetic analyses of non-isothermal data were best described by each of the dimensional phase boundary R-2 and two-dimensional diffusion controlled reactions D-2. While the capillary technique showed that the initial reaction occurs at the phase boundary of the reactants and kinetically of the reacting controlled by diffusion mechanism in which the diffusion species through the product layers are the organic acids.
查看更多

同类化合物

(甲基3-(二甲基氨基)-2-苯基-2H-azirene-2-羧酸乙酯) (±)-盐酸氯吡格雷 (±)-丙酰肉碱氯化物 (d(CH2)51,Tyr(Me)2,Arg8)-血管加压素 (S)-(+)-α-氨基-4-羧基-2-甲基苯乙酸 (S)-阿拉考特盐酸盐 (S)-赖诺普利-d5钠 (S)-2-氨基-5-氧代己酸,氢溴酸盐 (S)-2-[[[(1R,2R)-2-[[[3,5-双(叔丁基)-2-羟基苯基]亚甲基]氨基]环己基]硫脲基]-N-苄基-N,3,3-三甲基丁酰胺 (S)-2-[3-[(1R,2R)-2-(二丙基氨基)环己基]硫脲基]-N-异丙基-3,3-二甲基丁酰胺 (S)-1-(4-氨基氧基乙酰胺基苄基)乙二胺四乙酸 (S)-1-[N-[3-苯基-1-[(苯基甲氧基)羰基]丙基]-L-丙氨酰基]-L-脯氨酸 (R)-乙基N-甲酰基-N-(1-苯乙基)甘氨酸 (R)-丙酰肉碱-d3氯化物 (R)-4-N-Cbz-哌嗪-2-甲酸甲酯 (R)-3-氨基-2-苄基丙酸盐酸盐 (R)-1-(3-溴-2-甲基-1-氧丙基)-L-脯氨酸 (N-[(苄氧基)羰基]丙氨酰-N〜5〜-(diaminomethylidene)鸟氨酸) (6-氯-2-吲哚基甲基)乙酰氨基丙二酸二乙酯 (4R)-N-亚硝基噻唑烷-4-羧酸 (3R)-1-噻-4-氮杂螺[4.4]壬烷-3-羧酸 (3-硝基-1H-1,2,4-三唑-1-基)乙酸乙酯 (2S,4R)-Boc-4-环己基-吡咯烷-2-羧酸 (2S,3S,5S)-2-氨基-3-羟基-1,6-二苯己烷-5-N-氨基甲酰基-L-缬氨酸 (2S,3S)-3-((S)-1-((1-(4-氟苯基)-1H-1,2,3-三唑-4-基)-甲基氨基)-1-氧-3-(噻唑-4-基)丙-2-基氨基甲酰基)-环氧乙烷-2-羧酸 (2S)-2,6-二氨基-N-[4-(5-氟-1,3-苯并噻唑-2-基)-2-甲基苯基]己酰胺二盐酸盐 (2S)-2-氨基-N,3,3-三甲基-N-(苯甲基)丁酰胺 (2S)-2-氨基-3-甲基-N-2-吡啶基丁酰胺 (2S)-2-氨基-3,3-二甲基-N-(苯基甲基)丁酰胺, (2S)-2-氨基-3,3-二甲基-N-2-吡啶基丁酰胺 (2S,4R)-1-((S)-2-氨基-3,3-二甲基丁酰基)-4-羟基-N-(4-(4-甲基噻唑-5-基)苄基)吡咯烷-2-甲酰胺盐酸盐 (2R,3'S)苯那普利叔丁基酯d5 (2R)-2-氨基-3,3-二甲基-N-(苯甲基)丁酰胺 (2-氯丙烯基)草酰氯 (1S,3S,5S)-2-Boc-2-氮杂双环[3.1.0]己烷-3-羧酸 (1R,5R,6R)-5-(1-乙基丙氧基)-7-氧杂双环[4.1.0]庚-3-烯-3-羧酸乙基酯 (1R,4R,5S,6R)-4-氨基-2-氧杂双环[3.1.0]己烷-4,6-二羧酸 齐特巴坦 齐德巴坦钠盐 齐墩果-12-烯-28-酸,2,3-二羟基-,苯基甲基酯,(2a,3a)- 齐墩果-12-烯-28-酸,2,3-二羟基-,羧基甲基酯,(2a,3b)-(9CI) 黄酮-8-乙酸二甲氨基乙基酯 黄荧菌素 黄体生成激素释放激素(1-6) 黄体生成激素释放激素 (1-5) 酰肼 黄体瑞林 麦醇溶蛋白 麦角硫因 麦芽聚糖六乙酸酯 麦根酸